Twist PCR-Free WGS Library Preparation Kit

Twist Bioscience Logo White
Twist PCR-Free WGS Library Preparation Kit

The Twist PCR-Free WGS Library Preparation Kit is engineered for researchers who need their sequencing data to reflect the genome as it actually exists — not as amplification has reshaped it. By eliminating the PCR amplification step entirely, this kit preserves native genome representation from the outset, removing the single greatest source of coverage bias in whole genome sequencing workflows. Built on Twist’s optimised enzymatic fragmentation and high-efficiency ligation chemistry, the workflow delivers consistent insert sizes, minimised ligation bias, and uniform genome-wide coverage that supports confident variant characterisation from the first run.

Designed to scale from individual research projects to population-level sequencing studies, the PCR-Free WGS kit supports multiplexing of up to 1,536 samples per run via Twist’s full-length unique dual index (UDI) adapters — making it equally suited to high-throughput core laboratories and discovery programmes with large cohort requirements. As your authorised Australian distributor, Decode Science can support you with kit configurations, protocol guidance, and compatibility assessment for your sequencing platform and informatics pipeline.

Exclusive Offer for now!!

50% off 16 sample workflow kits & 50% off 96 sample kits. 

Submit Your Interest

Data

Why

It Matters

Download Instantly

Know in Detail

But... Why Choose PCR-Free WGS Library Prep?

Amplification-Free Prep for Native Genome

Minimised Ligation Bias for Maximum Conversion

Consistent Insert Size Control Across a Wide Input Range

Scale to 1,536-Plex Without Sacrificing Data Quality

Product Data: Performance Where It Counts

Robust Library Yield Maintained at Low Input

The PCR-Free WGS kit delivers strong library yields and consistent library size distribution even as DNA input is reduced, outperforming competitor PCR-free workflows at equivalent input levels. Efficient ligation chemistry drives conversion across input amounts — producing sequencer-ready libraries that don’t require amplification rescue when input is reduced.

Figure 1. PCR-free library yield comparison across inputs. Final library concentration (nM) was measured following PCR-free library preparation using the indicated DNA inputs. Twist PCR-Free WGS Library Preparation generated higher library yields than competitor workflows at equivalent inputs and maintained strong performance at lower inputs.

Reproducible Insert Size Control From 300 ng to 37.5 ng

Median insert sizes remain consistent across the full supported input range, from 300 ng down to 37.5 ng. Minimal read overlap across samples in this range confirms that fragment size control is maintained regardless of input quantity — supporting dependable genome-wide coverage without depth fluctuation between samples.

Figure 2. The kit produces consistently large inserts across a wide range of DNA samples. (A)Median Insert Size is represented for 300 ng, 75 ng, and 37.5 ng of NA12878 DNA sample input. (B) Percent Overlap (which measures how much paired-end sequencing reads redundantly cover the same DNA bases) is represented for 300 ng, 75 ng, and 37.5 ng of NA12878 sample input.

Tunable Fragment Lengths for Workflow Flexibility

Enzymatic fragmentation parameters can be adjusted to produce insert size distributions matched to the requirements of your sequencing platform and read length. This gives laboratories flexibility to optimise the prep for their specific instruments and analysis pipelines without sacrificing inter-batch reproducibility.

Figure 3. Tunability of Twist PCR-Free WGS Library Prep Kit.

A: Five electropherograms of NGS libraries generated using differing fragmentation times. 50 ng of high-quality gDNA was fragmented for various times at 32°C.

Consistent GC Coverage Across All Input Levels

One of the most persistent sources of WGS data quality problems is differential coverage across GC content — PCR amplification exacerbates this by further enriching already-accessible fragments. By removing amplification, the PCR-Free WGS kit maintains even coverage across GC content categories regardless of input, yielding cleaner, more interpretable genome-wide data.

Figure 4. The Twist PCR-Free WGS Library Preparation Kit provides more consistent coverage distribution across varying GC content. The kit shows minimized GC bias even at low inputs, thereby reducing the need for additional sequencing to achieve uniform coverage and better detection of variants in the high- and low-GC content regions.

Watch How It Works

Two steps to sequencer-ready whole genome libraries.

The PCR-Free WGS workflow is deliberately streamlined — complexity is removed at the chemistry level, not pushed onto the operator.

Step 1 — Enzymatic Fragmentation: Input DNA is enzymatically fragmented to produce consistent, tunable insert sizes across all samples in a batch. No sonication, no shear-related variability — just controlled, reproducible fragmentation that sets the foundation for uniform downstream coverage.

Step 2 — Adapter Ligation: Twist’s optimised ligase chemistry maximises adapter conversion efficiency while minimising ligation bias. The result is a sequencer-ready library that accurately represents the molecular diversity of your input, with no amplification step introducing artificial enrichment of any genomic region.

Why It Matters to You?

Because Whole Genome Sequencing Is Only as Good as What It Captures

Whole genome sequencing is increasingly the method of choice for variant discovery, structural analysis, and population-scale genomics — but the value of WGS data depends entirely on whether the library faithfully represents the genome that went into it. Amplification-based workflows introduce systematic biases that are difficult to distinguish from true biological signal, particularly in AT-rich regions, repetitive elements, and low-complexity sequences.

The PCR-Free WGS kit addresses this directly. Its impact is most relevant for:

Population and cohort genomics

 Large-scale studies demand per-sample consistency, reproducible coverage distributions, and the ability to scale indexing without index hopping or sample cross-contamination. UDI adapter compatibility and 1,536-plex capacity make this feasible at production scale.

Structural variant and CNV detection

Accurate copy number and structural variant calls depend on even baseline coverage across the genome. Amplification-induced regional bias creates false signals that complicate interpretation; PCR-free prep removes this confounder at source.

Germline variant discovery

Comprehensive, unbiased genome representation is the baseline requirement for germline variant calling, particularly in regions with extreme GC content or repetitive architecture that amplification-based methods handle poorly.

High-throughput sequencing cores

Consistent insert sizes, robust yields across a range of inputs, and multiplexing capacity that scales to 1,536 samples translate directly to higher instrument utilisation and lower per-sample sequencing cost.

Chris Wicky

Clinical Genomics Manager - ANZ & Country Manager - NZ

Planning a whole genome sequencing study or scaling an existing one?
 
Our team can help you assess input requirements, multiplexing strategy, and expected data output for your specific application. 

Related Products

Twist TrueAmp Library Prep Kit

High-fidelity amplification-based library prep for target enrichment and challenging low-input or FFPE samples

Twist Custom NGS Panels

Design and order target enrichment panels tailored to your gene list or genomic region of interest

Twist Exome 2.0

Comprehensive exome capture panel with proven uniformity across canonical and difficult targets

Resources

Download PCR-Free WGS Library Prep Product Sheet

Unlock with quick sign up!

    FAQs

     Amplification-free workflows are more sensitive to input DNA quality than PCR-based methods, as there is no amplification step to recover yield from degraded material. High molecular weight, intact genomic DNA is recommended. If your samples are degraded or of variable quality, the Twist TrueAmp Library Preparation Kit may be a better fit — contact Decode Science to discuss.

     The PCR-Free WGS kit maintains robust performance from 300 ng down to 37.5 ng DNA input, with consistent insert sizes and sequencing-ready yields across this range.

    The kit is compatible with Twist’s full-length UDI adapter system, supporting multiplexing of up to 1,536 uniquely indexed samples per sequencing run.

    In direct comparisons, the PCR-Free WGS kit delivers higher library yields than competitor PCR-free workflows at equivalent inputs. The absence of amplification removes duplicate reads from the sequencing output, meaning a greater proportion of reads generated are informative — improving effective sequencing depth per run.

     The kit is compatible with Illumina sequencing platforms. Contact Decode Science for guidance on read length optimisation and coverage depth requirements for your specific platform and study design.

     Yes. Amplification-free library prep is particularly well-suited to structural variant and copy number variant analysis, where even baseline coverage is essential. Removing PCR-induced regional enrichment reduces false positive signals in copy number calling.

    The Twist PCR-Free WGS Library Preparation Kit protocol is available from Decode Science on request.

    Talk to Us About PCR-Free WGS

    We only need these information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.



      BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

      You agree to receive communications from Decode Science. View our Privacy Policy

      Twist TrueAmp Library Preparation Kit

      Twist Bioscience Logo White
      Twist TrueAmp Library Preparation Kit

      The Twist TrueAmp Library Preparation Kit is a precision-engineered solution for next-generation sequencing target enrichment workflows, purpose-built for laboratories that cannot afford to lose data from difficult samples. At its core is the Twist TrueAmp polymerase — a high-fidelity amplification enzyme optimised to suppress amplification-induced errors and GC-related bias, delivering the coverage uniformity your downstream variant analysis demands. Whether you’re working with pristine input or fighting the constraints of degraded FFPE material, TrueAmp is designed to keep your libraries representative and your results reproducible.

      Paired with optimised enzymatic fragmentation and a high-efficiency ligation step, the TrueAmp workflow delivers tunable, consistent insert sizes across a wide range of input quantities — making it well-suited to mixed-input workflows and scaled sequencing operations. From pre-capture yield to on-target coverage, every metric reflects the same design intent: higher library complexity, fewer reruns, and greater confidence in variant calls from the first pass. As your authorised Australian distributor, Decode Science can advise on kit configurations, protocol optimisation, and compatibility with your current target enrichment panels.

      Exclusive Offer for now!!

      50% off 16 sample workflow kits & 50% off 96 sample kits. 

      Submit Your Interest

      Data

      Why

      It Matters

      Download Instantly

      Know in Detail

      But... Why Choose TrueAmp Library Prep?

      Delivers Reliable Coverage Across the Hardest Genomic Regions

      High Conversion Efficiency From Low-Input and FFPE Samples

      High-Fidelity Amplification for Low VAF Variant Detection

      Consistent Fragment Sizes Across Inputs for Scalable Workflows

      Product Data: Performance Where It Counts

      Higher Yield and Coverage From Your Most Challenging Inputs

      When working with low-input or degraded FFPE DNA, pre-capture library yield is the first indicator of whether a prep has succeeded or failed. TrueAmp consistently delivers higher pre-capture yields alongside stronger mean target coverage — without sacrificing library complexity. The result is more sequenceable molecules from the same difficult starting material, fewer failed runs, and less pressure on irreplaceable samples.

      Figure 1. Performance comparison of enriched libraries with low-input FFPE degraded samples (DIN <2.2) between TrueAmp Library Preparation Kit and competitor K kit, demonstrating the optimal solution for challenging sample applications. (A) The Twist TrueAmp Library Preparation Kit generates superior pre-capture library yield, indicative of high library construction and amplification efficiency. (B) The Twist TrueAmp Library Preparation Kit shows higher library complexity when compared with the competitor’s kits. This allows for more unique DNA molecules that are sequenceable in the library, reducing sequencing costs. (C) Achieves higher coverage.

      Uniform Coverage With Fewer Zero-Coverage Targets

      Gaps in coverage are not just an inconvenience — in target enrichment workflows, they represent missed variants and incomplete answers. TrueAmp reduces the proportion of zero-coverage targets across captured regions, improving coverage uniformity and giving you greater confidence that every target in your panel has been adequately interrogated. What you sequence is what you intended to sequence.

      Figure 2. Performance comparison of enriched libraries with low-input FFPE degraded samples (DIN <2.2) between TrueAmp Library Preparation Kit and competitor K kit, demonstrating the optimal solution for challenging sample applications. (A) Delivers excellent coverage uniformity, measured by a lower fold-80 base penalty. (B) Reduced regions with no coverage, measured by Percentage of Zero Coverage Targets.

      Consistent Performance Across GC-Extreme Regions

      GC content remains one of the most persistent sources of coverage bias in NGS library preparation. The TrueAmp Polymerase Mix is specifically formulated to maintain uniform amplification across both high- and low-GC regions — and critically, this performance holds even as PCR cycle number increases. For panels that include regulatory elements, repetitive regions, or GC-skewed targets, this translates directly to more complete and trustworthy data.

      Figure 3. Normalized GC bias trace showing improved coverage of the Twist TrueAmp polymerase. Libraries were prepared with Twist TrueAmp Library Preparation Kit and amplified with different polymerases and cycles.

      Upper panel: Normalized coverage against GC window plots comparing polymerases at 3 cycles of PCR.
      Lower panel: Normalized coverage against GC window plots comparing polymerases at 16 cycles of PCR.

      Reproducible Fragment Sizes Across a Wide Input Range

      Fragment size consistency underpins downstream QC, sequencing performance, and batch-to-batch reproducibility. TrueAmp delivers tightly controlled insert size distributions across a broad range of input DNA quantities, making it well-suited to mixed-input batching strategies and high-throughput workflows where uniformity at scale is non-negotiable.

      Figure 4. Reliable library size with Twist TrueAmp Library Prep Kit, even from ultra-low inputs.

      500 ng, 100 ng, 50 ng, 10 ng and 1 ng (gDNA) were fragmented at 32°C. 3, 5, 6, 8, 10, and 14 cycles of PCR were utilized for amplification, respectively. Samples have been performed in duplicates.

      A: Electropherograms of NGS libraries generated with the Twist TrueAmp Library Preparation Kit.

      B: Concentration of libraries after amplification for various DNA inputs.

      Tunable Insert Sizes for Application-Specific Optimisation

      Not every workflow demands the same library architecture. TrueAmp’s enzymatic fragmentation step produces repeatable, tunable insert sizes that can be adjusted to match your sequencing platform requirements and downstream analysis needs — providing flexibility without sacrificing the reproducibility your pipeline depends on.

      Figure 5. Tunability of Twist TrueAmp Library Prep Kit.

      A: Five electropherograms of NGS libraries generated using differing fragmentation times. 50 ng of high-quality gDNA was fragmented for various times at 32°C. 6 cycles of PCR were utilized for amplification.
      B: Median insert size vs time. 50 ng of high-quality gDNA was fragmented for various times at 32°C. Amplification was performed using 6 cycles of PCR. Samples were captured using the Twist Exome 2.0 panel.

      Watch How TrueAmp Works

      Three steps. Consistent results.

      The TrueAmp workflow is built around three precision-optimised steps that together deliver libraries you can sequence with confidence:

      Step 1 — Enzymatic Fragmentation: Extracted DNA is fragmented enzymatically to produce consistent, tunable insert sizes — no sonication required, no shear-related variability.

      Step 2 — Adapter Ligation: An optimised Twist ligase formulation maximises adapter conversion efficiency while minimising ligation bias, preserving molecular diversity from the very first step.

      Step 3 — Amplification via TrueAmp Polymerase: High-fidelity amplification boosts yield from challenging templates, maintains coverage uniformity across GC extremes, and supports sensitive downstream variant detection.

      Why It Matters to You?

      Because the Hardest Samples Carry the Most Important Questions

      In translational research and clinical genomics, the samples most critical to a study are often the ones that are hardest to sequence. Archival FFPE blocks, fine-needle aspirates, liquid biopsy specimens, and low-cellularity tumour sections are routinely degraded, limited in quantity, or variable in quality — and standard library prep kits frequently fail them.

      TrueAmp was engineered specifically for this challenge. Its impact is most pronounced where it matters most:

      Oncology and somatic variant detection

      Low VAF variants in heterogeneous tumour samples require error suppression and high complexity to call reliably. TrueAmp’s fidelity advantage directly supports this.

      FFPE-derived biobanked samples

      Legacy tissue samples carry irreplaceable longitudinal or retrospective data. Higher pre-capture yields from degraded input means more of that data becomes sequenceable.

      Target enrichment workflows

      Coverage uniformity across all captured targets — including GC-extreme regions — is the difference between a complete and an incomplete picture of your panel of interest.

      High-throughput core laboratories

       Reproducible fragment sizes and consistent performance across input ranges simplify batch QC, reduce failed libraries, and increase instrument utilisation.

      Chris Wicky

      Clinical Genomics Manager - ANZ & Country Manager - NZ

      Working with FFPE, low-input, or otherwise challenging samples?
       
      Our team can help you assess whether TrueAmp fits your current workflow and what to expect from your first run.

      Related Products

      Twist PCR-Free WGS Library Preparation Kit

      Bias-free whole genome libraries from high-quality input DNA, no amplification required

      Twist Custom NGS Panels

      Design and order target enrichment panels tailored to your gene list or genomic region of interest

      Twist Exome 2.0

      Comprehensive exome capture panel with proven uniformity across canonical and difficult targets

      Resources

      FAQs

      TrueAmp is specifically validated for challenging input types including FFPE-derived DNA (DIN <2.2), low-input samples, and variable-quality clinical specimens. It also performs well with high-quality genomic DNA across a wide input range.

      Input requirements vary by sample type and downstream application. TrueAmp is designed to deliver high conversion efficiency even from low-input and degraded samples — contact Decode Science for guidance specific to your sample type and target enrichment panel.

      Yes. TrueAmp is validated for use with both the Twist Universal Adapter System and the Twist UMI Adapter System, supporting error correction workflows for somatic variant detection and liquid biopsy applications.

      Absolutely. TrueAmp is designed to integrate with the full Twist target enrichment ecosystem, including Twist Custom NGS Panels and standard off-the-shelf panels such as Twist Exome 2.0.

      In head-to-head benchmarking against a leading competitor kit (Competitor K), TrueAmp generated superior pre-capture library yields, higher library complexity, and greater mean target coverage from the same degraded FFPE input — preserving more sequenceable molecules from precious, limited-quantity samples.

      TrueAmp libraries are compatible with Illumina sequencing platforms. For platform-specific guidance, contact our team.

      Protocols for TrueAmp with both the Universal Adapter System and UMI Adapter System are available from Decode Science on request.

      Talk to Us About TrueAmp

      We only need these information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.



        BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

        You agree to receive communications from Decode Science. View our Privacy Policy

        Whole transcriptome single cell analysis for FFPE tissues

        Whole transcriptome single cell analysis for FFPE tissues

        Unlock with quick sign up!

          Downloads
          Single Cell Whole Transcriptome Analysis of Breast Cancer FFPE Samples Across Tumor Subtypes

          Key Takeaways

          1. Whole transcriptome single cell profiling from archival FFPE breast cancer samples resolves tumor, stromal, and immune compartments in a single experiment
          2. Distinct epithelial programs are identified across clinically relevant subtypes, including ER+, ER/PR+, HER2+, and TNBC
          3. Subtype- and proliferation-associated lncRNA expression patterns are captured, highlighting the value of unbiased RNA profiling in FFPE samples

          Experimental Design:

          Formalin-fixed, paraffin-embedded (FFPE) tissue represents a vast source of clinically annotated samples, but has been difficult to use for whole transcriptome single cell analysis. In this dataset, nuclei isolated from 4 archived breast cancer FFPE samples were profiled using Evercode WT FFPE’s reverse transcription–based workflow designed to capture whole transcriptome expression from degraded RNA, profiling over 100,000 nuclei.

          These results demonstrate that FFPE samples enable whole transcriptome profiling that captures meaningful cell types and tumor subtype biology across multiple donors while preserving cellular heterogeneity.

          Results:

          Whole transcriptome profiling resolved epithelial tumor populations alongside stromal and immune compartments, including CAFs, endothelial cells, VSMCs, myeloid cells, pDCs, B cells, NKT cells, and mast cells.

          Cells cluster strongly by donor, with clear differences in gene expression programs across samples. Subtype-specific expression patterns distinguish ER+, ER/PR+, HER2+, and TNBC tumors, with TNBC remaining particularly distinct after integration.

          Figure 1: UMAP of human breast cancer FFPE nuclei. Tumor and proliferative epithelial states are resolved together with stromal and immune populations from FFPE samples.

          Subtype- and state-associated lncRNA expression

          Whole transcriptome profiling enables detection of biologically relevant lncRNAs across breast tumor cell states, revealing patterns linked to both tumor subtype and functional cell state.

          LINC00993, a lncRNA associated with tumor-suppressive activity in breast cancer, is enriched in luminal epithelial populations. In contrast, the oncogenic lncRNA TUG1 shows higher expression in TNBC and proliferating epithelial states. These patterns are consistent with known subtype-associated biology and highlight how lncRNA expression reflects underlying tumor programs.

          Figure 3: Proliferation-associated lncRNA expression.

          Expression of TUG1 and additional lncRNAs across proliferating epithelial populations marked by Ki67 protein expression. Proliferating tumor cells show increased expression of specific lncRNAs, linking noncoding RNA activity to cell cycle state.

          Proliferating epithelial populations show coordinated expression of TUG1 alongside proliferation markers, indicating an association between lncRNA activity and cell cycle progression.

          Together, these results demonstrate that whole transcriptome FFPE profiling captures both coding and noncoding features of tumor biology across subtype and cell state.

          Figure 2: Subtype-associated lncRNA expression across breast tumor cell states.

          To further connect lncRNA expression with functional and clinical measures of proliferation, lncRNA expression was assessed using Ki67 positivity, as determined by prior immunohistochemistry protein staining.

          Dot plot showing expression of LINC00993 and TUG1 across annotated cell populations. LINC00993 is enriched in luminal epithelial populations, while TUG1 is elevated in TNBC and proliferating epithelial populations. Dot size indicates the percent of cells expressing each transcript and color indicates average expression.

          Dr. Ebru Boslem

          ANZ Market Manager - Research Genomics

          As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

          MosaiX Library Prep Kit

          High-Complexity Libraries in 90 Minutes — With the Lowest Insertion Bias on the Market

          Download Instant Resources

          View Product Comparison Chart

          What Is MosaiX™?

          MosaiX™ Library Prep Kit from seqWell combines the speed of tagmentation with the precision of ligation-based methods — without compromise. At its core is TnX, a next-generation engineered transposase that dramatically reduces the insertion site bias associated with conventional Tn5 enzymes. The result is libraries with exceptional molecular complexity, uniform coverage, and minimal duplication — from as little as 1 ng of input DNA.

          Whether you’re scaling population genomics studies, performing whole genome or exome sequencing, or running targeted capture panels across human, plant, or animal samples, MosaiX delivers publication-ready data with a workflow that fits into a single morning. Directional tagmentation means you spend less time troubleshooting and more time generating insights.

          seqWell’s Directional Tagmentation ...complexity made simple

          TnX: Next-Generation Transposase

          Engineered for reduced insertion site bias compared to standard Tn5, TnX consistently accesses difficult genomic regions — including clinically relevant exome targets that other methods miss.

          90-Minute Workflow, 35 Minutes Hands-On

          From DNA to sequencer-ready library in under two hours. Minimal hands-on steps mean you can process more samples with less effort and fewer errors.

          High Complexity, Low Duplication

          MosaiX libraries routinely outperform bead-linked Tn5 preparations in library complexity and duplication rates — giving you more usable data per sequencing run.

          Flexible Input & Broad Compatibility

          Works with 1–50 ng gDNA in common buffers (Tris, TE, water). Compatible with all Illumina platforms, plus Element AVITI™ and Complete Genomics via conversion kits.

          seqWell Directional Tagmentation vs MosaiX 90-minute Workflow

          Chris Wicky

          Clinical Sales Manager - ANZ Country Manager - NZ

          Need help choosing the right kit for your application? Our technical specialists are ready to advise — reach out now and we’ll respond within the hour.

          The TnX Difference
          Reduced insertion site bias

          Read start site insertion bias was measured by examining the frequency of bases in the first 9 bases of each read. Positions with higher per-base nucleotide bias are represented by heights for hyperactive Tn5 and TnX, and illustrate the reduced bias of TnX.

          Why It Matters to You

          Traditional tagmentation is fast but...

          comes with trade-offs: insertion bias, lower complexity, and missed targets. Ligation methods deliver quality but demand time and technical finesse. MosaiX bridges that gap.

          For labs running population-scale studies,

          every percentage point in duplication rate and every missed exon target translates to wasted sequencing spend and compromised variant calls. With MosaiX, you're not choosing between throughput and data quality — you're getting both.

          Independent benchmarking shows MosaiX libraries

          achieve higher coverage uniformity and capture difficult genomic regions that bead-linked Tn5 preparations consistently miss. If your research depends on complete, unbiased representation of the genome, this is the kit that delivers.

          Ligation-Grade Performance. Tagmentation-Level Simplicity.
          Whole Exome Sequencing

          Benchmark-Matched Quality With a Fraction of the Effort

          When evaluated against the gold standard of enzymatic fragmentation followed by ligation, MosaiX-prepared libraries delivered virtually identical exome metrics at 6 Gb sequencing depth. But here’s where it gets interesting: compared to bead-linked Tn5 tagmentation, MosaiX consistently outperformed across the metrics that matter most — lower duplication rates, higher library complexity (as measured by HS Library Size), and fewer zero-coverage targets.

          That last point deserves emphasis. Zero-coverage targets represent gaps in your data — regions you sequenced but couldn’t see. In exome studies, those gaps can mean missed variants in clinically actionable genes. MosaiX closes those gaps.

          50 ng NA12878 genomic DNA (Genome in a Bottle reference) was used across all conditions. Libraries were prepared according to each manufacturer's protocol, captured using Twist Bioscience Exome 2.0 panel with standard workflow, and sequenced on NextSeq 2000. Data were down-sampled to 6 Gb per library and aligned to Twist exome capture targets on hg38.

          TnX finds those missing exome targets!
          Your Tn5 Libraries Might Be Missing Clinically Relevant Exons

          Standard bead-linked tagmentation using conventional Tn5 has a known weakness: insertion site sequence bias. This bias creates systematic blind spots — regions of the genome where the transposase preferentially avoids inserting, resulting in poor or absent coverage.

          In exome sequencing, this isn’t a minor inconvenience. It means clinically relevant targets can fall into coverage gaps, leading to missed variant calls in genes that could inform diagnosis or treatment decisions.

          TnX was engineered specifically to address this limitation. Its reduced insertion bias, combined with the higher molecular complexity of MosaiX libraries, enables access to difficult genomic regions that Tn5-based methods routinely underrepresent.

          The practical outcome: fewer zero-coverage targets, more complete exome representation, and greater confidence in your variant calls.

          Whole Genome Sequencing

          At matched sequencing depth (105 Gb, down-sampled from NovaSeq X+ 25B), MosaiX libraries achieved higher mean coverage than bead-linked Tn5 preparations. Duplication rates were lower. Estimated library size — a direct indicator of molecular complexity — was higher.

          What does this mean in practice?

          You’re extracting more unique, mappable information from every gigabase of sequencing output. For population-scale studies or projects where sequencing cost is a limiting factor, that efficiency translates directly to better data economics.

          Method: 50 ng of NA12878 DNA (Genome in a Bottle) was used in both and libraries were prepared following manufacturers’ user guides. Sequencing was performed on a lane of a NovaSeq X+ 25B flow cell, down-sampled to 105 Gb each, then aligned to hg38.

          Chris Wicky

          Clinical Sales Manager - ANZ Country Manager - NZ

          Ready to trial MosaiX in your lab?

          Get in touch with our team — we’ll have pricing and availability to you within 24 hours.

          MosaiX Specifications

          Early Access MosaiX Library Prep Kit Includes:

          TnX Read 1 Tagging Reagent
          5X Reaction Buffer
          Tagmentation Enhancer
          Read 2 Adapter
          DNA Ligase
          2X Amplification Ready Mix
          MAGwise Paramagnetic Beads
          Diluent

          MosaiX Specifications

          FAQs

          MosaiX is optimised for purified genomic DNA from human, plant, or animal sources. Input can range from 1–50 ng, though inputs below 5 ng may require optimisation of adapter concentration and PCR cycles.

          Yes. MosaiX libraries are compatible with all Illumina sequencing platforms. For Element AVITI™ or Complete Genomics systems, use the appropriate Illumina library conversion kit.

          TnX is an engineered transposase with significantly reduced insertion site sequence bias. This results in higher library complexity, lower duplication rates, and better access to difficult genomic regions compared to conventional Tn5-based methods.

          MosaiX is compatible with any tagmentation-compatible indexing primers. Kits include 24 or 96 unique dual index (UDI) primers.

          Absolutely. MosaiX has been validated for whole exome sequencing (WES) and targeted capture panels, with benchmarking data showing improved performance over bead-linked Tn5 methods for these applications.

          Each kit contains: TnX Read 1 Tagging Reagent, 5X Reaction Buffer, Tagmentation Enhancer, Read 2 Adapter, DNA Ligase, 2X Amplification Ready Mix, MAGwise Paramagnetic Beads, and Diluent.

          Do you have a question?

          Our team is one form away.

          We only need below information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.



            BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

            You agree to receive communications from Decode Science. View our Privacy Policy

            Evercode™ Whole Transcriptome v4

            Introducing Evercode™ Whole Transcriptome v4

            Evercode™ Whole Transcriptome v4 from Parse Biosciences delivers higher sensitivity single cell transcriptomics with a streamlined, instrument-free workflow built for labs ready to scale.

            Detect More Biology from Every Cell — Without Adding Instruments to Your Bench

            Single cell RNA sequencing has transformed how we interrogate complex tissues, immune repertoires, and disease biology — but for many labs, the barriers to entry and scale remain real. Instrument dependencies and low cell recovery have limited what’s practically achievable. Evercode™ Whole Transcriptome v4 addresses these constraints directly. Built on Parse Biosciences’ proven combinatorial barcoding chemistry, v4 enhances transcript and gene detection efficiency across sequencing depths, giving you sharper resolution of rare cell populations and lowly expressed genes without requiring specialised hardware.

            What makes v4 a meaningful step forward is the combination of improved sensitivity with a redesigned, bead-based workflow. Centrifugation steps have been replaced with magnetic bead clean-up, resulting in up to 75% higher cell retention — a significant gain when working with limited or precious samples. Fewer pipetting steps, greater automation compatibility, and increased confidence at critical handling stages mean your experiments scale more reliably, whether you’re processing a handful of samples or running large cohort studies across conditions and replicates.

            A History of Innovation. Now Even Greater Sensitivity.

            Higher Sensitivity, Greater Biological Resolution

            Improves transcript detection efficiency at every sequencing depth. Clearer identification of rare cell states and detection of genes.

            Instrument-Free Scalability

            No capital equipment purchase.
            No booking time on a shared instrument.
            Single cell experiments start with a standard cell or nuclei suspension and a set of reagent plates — nothing more.

            Bead-Based Workflow for Higher Cell Recovery

            Retaining up to 75% more cells through critical clean-up steps.

            Built for Automation and Reproducibility

            Highly compatible with liquid handling systems, supporting consistent results across operators and sites.

            Watch What the Leaders Have To Say

            They talk about the problem they are trying to solve for a researcher, how has the feedback received from customers influenced the evolution of Evercode and more....

            Ebru Boslem, PhD

            ANZ Market Manager - Research Genomics

            Our specialist team can advise on experimental design, sample preparation, and sequencing strategy — reach out to me directly and we can discuss your needs.

            Why It Matters to You

            1. For Immunology & Oncology Researchers

            Pair whole transcriptome profiling with Evercode TCR or BCR kits to connect clonotype identity with transcriptional phenotype at single cell resolution.

            2. For Oncology & Tumour Biology Labs

            Higher gene detection per cell means better characterisation of malignant subpopulations, stromal interactions, and therapy-resistant states — even in samples with limited cell numbers from biopsies or PDX models.

            3. For Cardiomyocyte and Complex Tissues Studies

            Perfect for large cell types which may clog the microfluidic single cell instruments. Parse combinatorial barcoding occurs in plates inside fixed cell eliminating the need for cell suspension flow that can damage & stress cells.

            4. For Core Facilities & Service Labs

            v4's automation-ready workflow and consistent performance across operators reduce turnaround times and support diverse project demands without tying up instrument slots.

            Explore Competitive Comparisons
            Comparison 1: Evercode™ WT v4 vs. Chromium™ GEM-X Single Cell 3' v4 — Human PBMCs

            When tested head-to-head using frozen PBMCs from two donors processed in independent labs, Evercode WT v4 demonstrated a clear increase in transcript detection compared to the Chromium GEM-X 3′ platform. Cell type proportions were equivalently represented across both technologies, confirming that Evercode’s combinatorial barcoding approach captures the same biological diversity — with the added advantage of lower ambient RNA contamination and a significant reduction in mitochondrial and ribosomal read content. For labs looking to maximise usable data per read, that’s sequencing budget going directly toward biology rather than noise.

            Download Tech Note
            Instantly!

              Comparison of Evercode™ WT v4 and Chromium™ GEM-X Single Cell 3’ Kit v4 in Human PBMCs

              Gene Detection. Median genes detected per cell across different sequencing depths for PBMC donor 1 (top) and PBMC donor 2 (bottom). Aliquots derived from the same donor cryovial lot were distributed to separate laboratories for processing with either Evercode WT v4 or Chromium GEM-X 3’ v4 workflows and analyzed using their respective data analysis pipelines.

              Comparison 2: Evercode™ WT v4 vs. Chromium™ Flex v2 (Apex) — Fixed Human PBMCs

              In a parallel comparison using fixed PBMCs, Evercode WT v4 retained over four times the number of cells through processing and detected more than 60% higher median transcripts per cell — including diverse RNA biotypes that probe-based approaches can miss entirely. Because Evercode uses an RT-based method rather than predefined probe panels, you’re not limited to a curated gene list; you capture the full transcriptional landscape of each cell. For researchers working with fixed clinical samples or multi-site collections, this means more cells, more genes, and more confidence in what the data is telling you.

              Download Tech Note
              Instantly!

                Detected Transcripts and RNA Biotypes Comparison. Total transcripts detected in human PBMCs across sequencing depths, including protein-coding genes and other RNA biotypes. Other biotypes comprise lncRNA, miRNA, snRNA, snoRNA, miscRNA, pseudogenes, and Ig/TCR genes.

                Cell Retention & Assay Time. Overall retention rates were calculated by multiplying stepwise retention across all samples, and total assay times were based on vendor recommendations for four PBMC aliquots.

                Related Products

                Evercode™ Whole Transcriptome Range

                Evercode WT Mini — Ideal for pilot studies and labs getting started with single cell. Profile up to 10,000 cells per sample.

                Evercode WT — The standard configuration for most single cell transcriptomics experiments.

                Evercode WT Mega — Designed for larger experiments requiring higher cell throughput per run.

                Evercode WT Penta — Maximum scale for ambitious, multi-sample study designs.

                Immune Profiling

                Evercode TCR — Paired T cell receptor sequencing with whole transcriptome at single cell resolution.

                Evercode BCR — Paired B cell receptor sequencing with whole transcriptome at single cell resolution.

                Additional Capabilities

                Evercode Fixation — Fix samples at the point of collection and process later — ideal for clinical workflows and multi-site studies.

                Gene Select — Targeted gene panels to reduce sequencing costs while retaining biological insight.

                CRISPR Detect — Single cell readouts for pooled CRISPR screening experiments.

                Do you have a question?

                Our team is one form away.

                We only need below information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.



                  BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

                  You agree to receive communications from Decode Science. View our Privacy Policy

                  MGISTP-B1000

                  MGI STP-B1000

                  The STP-B1000 is designed for laboratories that require accurate, repeatable separation and transfer of blood components without compromising traceability or efficiency. It precisely recognizes plasma, buffy coat, and red blood cells within centrifuged blood collection tubes and transfers each component with high positional accuracy, reducing manual handling and the risk of cross-contamination. Integrated barcode tracking ensures every transfer remains fully traceable, preventing sample mismatches and data integrity issues in high-throughput workflows.

                  Operation is intentionally streamlined… users define only the component type, transfer volume, and number of transfers before initiating the process with a single click. This simplicity minimizes training requirements while delivering consistent, standardized blood processing suitable for clinical, biobanking, and research applications.

                  Accurately Identify Blood Components & efficiently recover the buffy coat

                  Precise Layer Positioning

                  Dual light photography, high-definition camera, built-in self developed image processing

                  Efficient Buffy Coat Recovery

                  Spiral aspirate, 3-axis linkage control & recovery rate of 95% or more

                  Dual Detection Technology

                  Pressure based liquid level detection (pLLD) & capacitive liquid level detection (cLLD)

                  Chris Wicky

                  Clinical Genomics Manager - ANZ & Country Manager - NZ

                  As the official distributor of MGI in Australia and New Zealand, Decode Science is providing local access to STP-B1000 solutions with region-based technical and application support. Simply talk to me and we can discuss your research needs.

                  Product Components & Software Functions

                  Integrated Scanning, Identification, Transferring

                  Download Brochure Instantly!

                    Product Specifications
                    IndicatorsParameter
                    PipettorPipette Range
                    1 μL–1000 μL
                    Pipette Accuracy
                    1 μL: CV≤8%, accuracy: ±10%
                    50 μL: CV≤1%, accuracy: ±2%
                    200 μL: CV≤1%, accuracy: ±2%
                    1000 μL: CV≤1%, accuracy: ±1%
                    Independent 8-channel Pipettor
                    Detection ModepLLD, cLLD
                    Throughput1–192 samples/run
                    Size1420 mm (L) × 1010 mm (W) (without door handle) × 1120 mm (H)
                    Weight~250 kg
                    MGI Portfolio

                    Contact Decode Science Today

                    We only need these information to serve you better. Decode Science respects your privacy and will never spam you with unrelated content.



                      BioinformaticsCloningCRISPREpigeneticsGenomicsLong ReadMetagenomicsMicrobiomeNeurologyProteinRNASingle CellSpatialSmall RNASynthetic BiologyOther

                      You agree to receive communications from Decode Science. View our Privacy Policy

                      BiOptic Customisable Fragment Analysis

                      Cost-Effective Customisable Fragment Analysis.

                      Customisable Qsep solutions for genomics labs — up to 4x more cost-effective with faster turnaround times than traditional systems.

                      Bioptic
                      Scott Coutts

                      Clinical Field Application Scientist

                      Jiyoti Verma

                      Field Application Scientist

                      Fragment analysis shouldn’t slow your research down. Many genomics labs and core facilities struggle with:

                      How about custom-configured Qsep bio-fragment analysers?

                      Decode Science provides custom-configured Qsep bio-fragment analysers designed for academic labs and core facilities that need:

                      A system configured to your workflow

                      Support to optimise how you run it

                      Lower operating costs without sacrificing performance

                      Backed by:

                      How It Works

                      1

                      Insert the gel cartridge

                      2

                      Load Sample & Buffer

                      3

                      Run Q- Analyser

                      Results in 2–7 minutes

                      Easy to operate: 3 mins to set up and start

                      No need for gel and sample preparation

                      High sensitivity: 5 pg/μl can be detected

                      High resolution: 1 to 4 bp resolution

                      Reliable sizing & quantitative result

                      Built for modern genomics workflows

                      NR1 Cartridge BiOptic

                      NGS library QC

                      NR1 Cartridge BiOptic

                      Genomic & plasmid DNA

                      NR1 Cartridge BiOptic

                      Multiplex PCR

                      NR1 Cartridge BiOptic

                      CRISPR workflows

                      NR1 Cartridge BiOptic

                      Low concentration RNA (ctDNA / cfDNA)

                      NR1 Cartridge BiOptic

                      SNP, RFLP, MDx

                      NR1 Cartridge BiOptic

                      Protein profiling & antibody purity

                      NR1 Cartridge BiOptic

                      Total RNA QC & fragment analysis

                      Proof it works — Fast, Sensitive, Reliable (performance of Qsep platforms)

                      1. Reproducibility: run the same marker x 50

                      2. Stability: same sample run at 3 different time points

                      3. Resolution: 1~4bp can be resolved below 500bp

                      4. High Sensitivity: Standard cartridge can detect down to 2 pg/ul, the sensitivity of the high sensitivity cartridge can be up to 10 times higher than the standard cartridge

                      cfDNA / ctDNA High-Demand Application

                      cfDNA Quality Control

                      Ebru Boslem

                      ANZ Market Manager - Research Genomics

                      As the official distributor of BiOptic in Australia and New Zealand, Decode Science makes advanced fragment analysis easy to adopt.

                      We provide local access to custom-configured Qsep bio-fragment analysers, helping genomics labs and core facilities run faster, more cost-effective workflows — without paying for features they don’t use.

                      Reach out to me directly for more info or a quick call to discuss further.

                      Trusted by Genomics Labs
                      and Core Facilities

                      How Can Decode Science Help You?

                      1

                      Submit Your Custom Request

                      This will be looked at by our team

                      2

                      Decode Team Schedules Meeting

                      This meeting will be the first session to understand your requirements ever further

                      3

                      Guide with the solution

                      Decode Science team will prepare a guide and help with your installation/set up

                      4

                      Ongoing Support Provided

                      For future support, simply reach out to the Decode representative.

                      we’re here to all your questions

                      Qsep platforms combine high sensitivity, fast turnaround (2–7 mins per run), and flexible configurations (1 – 100+ samples) — all at a significantly lower cost than traditional systems. You get performance without paying for features you don’t need.

                      Qsep supports DNA, RNA, and protein applications, including: NGS library QC, multiplex PCR, CRISPR workflows, SNP, RFLP, MDx, total RNA QC, low-concentration RNA, and protein profiling/antibody analysis.

                      You can select:

                      1. System configuration based on throughput needs

                      2. Cartridge types for specific applications

                      3. On-site FAS support and workflow consulting to align the system with your lab protocols

                      Typical run times are 2–7 minutes per sample depending on cartridge type and application. cfDNA / ctDNA runs can be as fast as 2–3 minutes per sample.

                      While we do not provide Demos, we ensure your lab heads are fully trained and supported, with ongoing Decode assistance for the first 3–6 months. Plus, our money-back guarantee means if you’re not satisfied, we’ll refund the instrument’s value.

                      Decode Science team
                      is well equipped to help you out.



                        Simoa Dry Blood Extraction Kit

                        Huber, H., Montoliu-Gaya, L., Brum, W.S. et al. A minimally invasive dried blood spot biomarker test for the detection of Alzheimer’s disease pathology. Nat Med (2026). https://doi.org/10.1038/s41591-025-04080-0

                        Simoa Dry Blood Extraction Kit

                        The Simoa Dry Blood Extraction Kit is a validated, device-agnostic solution for extracting analytes from dried plasma and dried blood spot (DPS/DBS) samples for use with Simoa® assays. It enables consistent, reproducible recovery of low-abundance biomarkers while maintaining the femtogram-level sensitivity required for clinical and translational research.

                        Designed to support decentralized and remote sample collection, the kit simplifies pre-analytical workflows without compromising data quality. It is well suited for longitudinal studies, multi-site trials, and settings where traditional venous sampling and cold-chain logistics are impractical.

                        Key Features of the Simoa Dry Blood Extraction Kit

                        Device-agnostic compatibility

                        Validated across multiple dried plasma and dried blood spot collection devices, enabling consistent analyte recovery independent of collection format. This supports reliable data generation across decentralized, remote, and longitudinal study designs.

                        Standardized, semi-automated workflow

                        A harmonized extraction protocol controls critical pre-analytical variables, including elution conditions, centrifugation parameters, and buffer composition. This reduces operator- and site-dependent variability and improves reproducibility across batches and study sites.

                        Preservation of analytical sensitivity

                        The extraction process is optimized to maintain the ultra-high sensitivity of Simoa® assays, enabling reliable detection of low-abundance biomarkers such as p-Tau 217. Suitable for neurological, inflammatory, and systemic biomarker applications where signal integrity is critical.

                        Direct compatibility with Simoa® assays

                        Designed specifically for downstream use with Simoa® kits, the workflow integrates into existing laboratory processes without the need for additional assay optimization or protocol development.

                        Clinical Evidence: DROP-AD Study (Nature Medicine)

                        Hanna Huber
                        Nutrition Scientist // Ph.D // Postdoctoral researcher @DZNE Bonn & University of Gothenburg

                        The Simoa Dry Blood Extraction Kit workflow is supported by evidence from the DROP-AD study, published in Nature Medicine, demonstrating that capillary dried blood samples can be used to reliably quantify key Alzheimer’s disease biomarkers.

                        The multi-centre European study showed strong concordance between capillary dried blood and conventional venous plasma measurements for:

                        1. p-Tau217 – strong correlation across multiple sites

                        2. GFAP and NfL – reliable quantification with high plasma concordance

                        The approach demonstrated good diagnostic accuracy for identifying CSF-confirmed Alzheimer’s pathology and high reproducibility with self-collected samples, supporting decentralized and remote study designs.

                        Importantly, the study confirms the feasibility of this approach in high-risk and underrepresented populations, including individuals with Down syndrome, and eliminates the need for venipuncture, centrifugation, and cold-chain logistics.

                        This workflow is intended for research use only and is not designed for clinical diagnosis or clinical decision-making.

                        Instant Download Simoa Dry Blood Extraction Kit Tech Note

                        Unlock with quick sign up!

                          Designed for Real-World Clinical and Research Workflows

                          The Simoa Dry Blood Extraction Kit is designed to support high-sensitivity biomarker analysis in settings where traditional venous sampling and cold-chain logistics are limiting.

                          For academic and translational neuroscience teams conducting large cohort or longitudinal studies, the kit provides a standardized method for extracting biomarkers from small-volume, remotely collected samples, reducing pre-analytical variability and improving inter-site comparability.

                          In pharmaceutical and biotechnology research, the workflow supports early-phase and decentralized study designs where sample volume is limited but analytical sensitivity is critical.

                          For public health and global research settings, the kit enables reliable laboratory-grade biomarker analysis from capillary dried blood samples, supporting studies in low-resource or geographically distributed populations.

                          Applications and Intended Use

                          The Simoa Dry Blood Extraction Kit is intended for the extraction of analytes from capillary-derived dried blood and plasma collection devices to support detection of low-abundance biomarkers using Simoa® assay kits.

                          For research use only.

                          Kit Contents

                          Each kit includes Quanterix extraction buffer and two precipitation plates.

                          Julia Young

                          Quanterix Business Manager

                          As the official distributor of Quanterix in Australia and New Zealand, Decode Science is providing local access to Simoa® platforms, assays, and workflow solutions with region-based technical and application support.

                          Quanterix Portfolio

                          Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

                          Proteomics in Transition: From Discovery to Diagnostic Relevance Whitepaper

                          For years, discovery proteomics uncovered hundreds of candidate biomarkers — but most stalled before reaching the clinic. New digital platforms change that: they deliver femtogram-level sensitivity, reproducible quantification across sites, and the analytical rigor required for regulatory and clinical use.

                          Why this matters
                          Proteins reflect real-time biology. That means faster detection, better trial enrollment, and clearer measures of therapeutic effect. Whether you’re developing a diagnostic, designing an adaptive trial, or building a multi-omics model, the right proteomic data reduces guesswork and accelerates decisions.

                          Quanterix Proteomics in Transition

                          Unlock with quick sign up!

                            Dr. Ebru Boslem

                            ANZ Market Manager - Research Genomics

                            As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.

                            BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

                            BCR Sequencing of 1 Million Healthy and Diseased Samples in a Single Experiment

                            Unlock with quick sign up!

                              Key Takeaways

                              1. Profiled 1 million human B cells in a single experiment

                              2. Detected 900,000+ unique paired clonotypes across Type 1 Diabetes, Multiple Sclerosis, Rheumatoid Arthritis, Crohn’s, Celiac, and healthy donors

                              3. Achieved sensitive detection of CDR3 regions, clonotypes, and full-length sequences at scale

                              Evercode BCR uncovered over 900,000 unique paired clonotypes across 24 samples in a single experiment. Negatively selected B cells from 12 healthy donors were purchased, while pan B cells were isolated from 12 autoimmune-diseased human PBMCs and fixed using the Evercode Cell Fixation Kit v3 to preserve cell structure and protect RNA integrity. Fixed samples were stored at -80°C until all were ready for combined processing with the Evercode BCR Mega Kit. Whole transcriptome and BCR-specific libraries were sequenced on the Illumina Novaseq X, and data were analyzed using Parse Biosciences’ Analysis Pipeline v1.3.0. Clustering with Seurat 5.0 showed that the majority of cells corresponded to major B cell subtypes, as illustrated in the UMAP below (Figure 1).

                              The assay demonstrated high sensitivity, detecting paired heavy and light chains in up to 89% of cells (Figure 2).

                              Downloads

                              Dr. Ebru Boslem

                              ANZ Market Manager - Research Genomics

                              As the official distributor in Australia and New Zealand, Decode Science makes accessing genomics solutions straightforward. Our role is to connect your lab with advanced technologies, ensuring you get the right solution for your sequencing projects—delivered locally with support when you need it.